Amyris, Inc. (AMRS): Price and Financial Metrics


Amyris, Inc. (AMRS): $4.07

0.14 (+3.56%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add AMRS to Watchlist
Sign Up

Industry: Chemicals


Ranked

of 90

in industry

AMRS POWR Grades


  • Momentum is the dimension where AMRS ranks best; there it ranks ahead of 48.1% of US stocks.
  • AMRS's strongest trending metric is Quality; it's been moving down over the last 170 days.
  • AMRS's current lowest rank is in the Stability metric (where it is better than 0.91% of US stocks).

AMRS Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for AMRS is -4 -- better than only 2.46% of US stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at -2.17 for Amyris Inc; that's greater than it is for only 3.84% of US stocks.
  • Revenue growth over the past 12 months for Amyris Inc comes in at 166.4%, a number that bests 95.63% of the US stocks we're tracking.
  • Stocks that are quantitatively similar to AMRS, based on their financial statements, market capitalization, and price volatility, are CPRX, ATEN, OSS, AUDC, and CODX.
  • AMRS's SEC filings can be seen here. And to visit Amyris Inc's official web site, go to www.amyris.com.

AMRS Valuation Summary

  • AMRS's price/sales ratio is 12; this is 650% higher than that of the median Basic Materials stock.
  • AMRS's price/sales ratio has moved up 2.2 over the prior 133 months.
  • AMRS's price/earnings ratio has moved down 0 over the prior 133 months.

Below are key valuation metrics over time for AMRS.

Stock Date P/S P/B P/E EV/EBIT
AMRS 2021-09-03 12.0 -33.7 -8.8 -11.2
AMRS 2021-09-02 13.0 -36.6 -9.6 -12.1
AMRS 2021-09-01 12.9 -36.3 -9.5 -12.0
AMRS 2021-08-31 13.1 -36.7 -9.6 -12.1
AMRS 2021-08-30 13.2 -37.0 -9.7 -12.2
AMRS 2021-08-27 13.9 -39.2 -10.3 -12.9

AMRS Growth Metrics

    Its 2 year revenue growth rate is now at 9.03%.
  • Its 3 year net income to common stockholders growth rate is now at -47.47%.
  • The 2 year net income to common stockholders growth rate now stands at -98.25%.
AMRS's revenue has moved up $271,691,000 over the prior 49 months.

The table below shows AMRS's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-09-30 356.785 -49.103 -415.835
2021-06-30 343.177 -35.216 -466.366
2021-03-31 320.866 -20.727 -585.795
2020-12-31 173.137 -175.753 -382.311
2020-09-30 133.929 -209.279 -352.02
2020-06-30 134.624 -209.008 -326.452

AMRS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • AMRS has a Quality Grade of C, ranking ahead of 43.65% of graded US stocks.
  • AMRS's asset turnover comes in at 1.143 -- ranking 10th of 89 Chemicals stocks.
  • MBII, SNES, and FTK are the stocks whose asset turnover ratios are most correlated with AMRS.

The table below shows AMRS's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 1.143 0.691 -0.949
2021-03-31 1.255 0.692 -1.442
2020-12-31 0.802 0.493 -1.092
2020-09-30 0.668 0.377 -0.965
2020-06-30 0.744 0.419 -1.139
2020-03-31 1.155 0.580 -1.003

AMRS Price Target

For more insight on analysts targets of AMRS, see our AMRS price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $22.83 Average Broker Recommendation 1.33 (Strong Buy)

AMRS Stock Price Chart Interactive Chart >

Price chart for AMRS

AMRS Price/Volume Stats

Current price $4.07 52-week high $23.42
Prev. close $3.93 52-week low $3.65
Day low $3.65 Volume 6,048,700
Day high $4.14 Avg. volume 7,218,753
50-day MA $5.49 Dividend yield N/A
200-day MA $11.87 Market Cap 1.25B

Amyris, Inc. (AMRS) Company Bio


Amyris, Inc. provides various alternatives to a range of petroleum-sourced products for the consumer care, specialty chemical, and transportation fuel markets worldwide. The company was founded in 2003 and is based in Emeryville, California.


AMRS Latest News Stream


Event/Time News Detail
Loading, please wait...

AMRS Latest Social Stream


Loading social stream, please wait...

View Full AMRS Social Stream

Latest AMRS News From Around the Web

Below are the latest news stories about Amyris Inc that investors may wish to consider to help them evaluate AMRS as an investment opportunity.

AMYRIS ANNOUNCES APPOINTMENT OF ANA DUTRA TO BOARD OF DIRECTORS

Amyris, Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic biotechnology company accelerating the world to sustainable consumption through its Lab-to-MarketTM operating platform, today announced the appointment of Ms. Ana Dutra as its newest independent member of the Amyris Board of Directors, effective January 21, 2022.

Yahoo | January 27, 2022

Amyris, Inc. (AMRS) Gains As Market Dips: What You Should Know

In the latest trading session, Amyris, Inc. (AMRS) closed at $4.23, marking a +0.48% move from the previous day.

Yahoo | January 26, 2022

Amyris to acquire women''s wellness company, MenoLabs

Amyris (AMRS) has agreed to exclusive terms to acquire the assets of MenoLabs, LLC, a growing women''s wellness brand focused on addressing perimenopause and menopause symptoms

Seeking Alpha | January 24, 2022

AMYRIS TO ACQUIRE MENOLABS FOR MENOPAUSE WELLNESS ACCELERATING GROWTH OF CONSUMER BUSINESS

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ operating platform announces that it has agreed to exclusive terms to acquire the assets of MenoLabs, LLC, a women-founded company to treat menopause symptoms, drive research for women's health and improve society's understanding of menopause.

Yahoo | January 24, 2022

Amyris: Success With RebM Will Indicate A Manufacturing Advantage

Amyris (AMRS) is a leading synthetic biology company that uses sugarcane fermentation to convert sugar into commercial molecules that are pure and sustainably sourced. Amyris’ primary focus is on the Clean Beauty and Health markets, making RebM a fringe asset rather than a strategic priority. RebM could be a reasonably...

Richard Durant on Seeking Alpha | January 19, 2022

Read More 'AMRS' Stories Here

AMRS Price Returns

1-mo -25.18%
3-mo -72.54%
6-mo -71.85%
1-year -56.70%
3-year 30.45%
5-year -54.78%
YTD -24.77%
2021 -12.39%
2020 99.84%
2019 -7.49%
2018 -10.93%
2017 -65.75%

Continue Researching AMRS

Want to see what other sources are saying about Amyris Inc's financials and stock price? Try the links below:

Amyris Inc (AMRS) Stock Price | Nasdaq
Amyris Inc (AMRS) Stock Quote, History and News - Yahoo Finance
Amyris Inc (AMRS) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7671 seconds.